Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | mitogen-activated protein kinase 14 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | mitogen-activated protein kinase 5 | mitogen-activated protein kinase 14 | 360 aa | 336 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | P2X receptor subunit | 0.1744 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1114 | 0.604 | 1 |
Schistosoma mansoni | P2X receptor subunit | 0.1744 | 1 | 1 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.1744 | 1 | 1 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0451 | 0.188 | 1 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.1114 | 0.604 | 0.604 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.1114 | 0.604 | 1 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.1114 | 0.604 | 1 |
Trypanosoma cruzi | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0389 | 0.149 | 0.2467 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.1744 | 1 | 1 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.1744 | 1 | 1 |
Schistosoma mansoni | P2X receptor subunit | 0.1744 | 1 | 1 |
Trypanosoma brucei | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0389 | 0.149 | 0.2467 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.1114 | 0.604 | 0.604 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.1744 | 1 | 1 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.1744 | 1 | 1 |
Brugia malayi | kinase, mitochondrial precursor | 0.1114 | 0.604 | 1 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.1114 | 0.604 | 0.0895 |
Schistosoma mansoni | P2X receptor subunit | 0.1744 | 1 | 1 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.1114 | 0.604 | 1 |
Leishmania major | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0389 | 0.149 | 0.2467 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.1114 | 0.604 | 0.604 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.01 uM | Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter | ChEMBL. | 22014550 |
IC50 (functional) | = 0.25 uM | Antiinflammatory activity in human PBMC assessed as inhibition of LPS-induced TNFalpha production preincubated for 1 hr before LPS challenge measured after 3 hrs by ELISA | ChEMBL. | 22014550 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 22014550 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.